Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc.

Track CRVS — free
$14.09 -0.37 (-2.56%) At close · Aug 24
Market Cap
$1.22B
Shares
84.12M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 173
Total Value: $1,087,562,209
Total Shares: 72,795,338

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 173 13F filers · Δ vs Mar 31, 2026
Top Holder
9.8%
Sep 2023 → Jun 2026 · range 9.8% – 38.7%
−0.2 pts
Top 5
35.5%
Sep 2023 → Jun 2026 · range 32.6% – 86.7%
+2.9 pts
Top 10
54.7%
Sep 2023 → Jun 2026 · range 50.8% – 95.2%
+3.9 pts
HHI
411
Sep 2023 → Jun 2026 · range 379 – 2,109
Broadly held+32

Quarterly Activity

vs Mar 31, 2026
New
40
Increased
72
Decreased
38
Sold Out
32
Unchanged
23
Holder count: +8
Institutional value: +3.7%
Shares held: +1.5%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 184
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 162 filings 159 filers Visit website Investor relations